Your browser doesn't support javascript.
loading
CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer.
Yoshida, Taku; Kim, Jee Hyun; Carver, Kristopher; Su, Ying; Weremowicz, Stanislawa; Mulvey, Laura; Yamamoto, Shoji; Brennan, Cameron; Mei, Shenglin; Long, Henry; Yao, Jun; Polyak, Kornelia.
Afiliación
  • Yoshida T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Kim JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Seoul National University College of Medicine, Seoul, Korea.
  • Carver K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Su Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Weremowicz S; Department of Pathology, Harvard Medical School, Boston, Massachusetts. Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Mulvey L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Yamamoto S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Brennan C; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Mei S; Center for Functional Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Bioinformatics, School of Life Science and Technology, Tongji University, Shanghai, China.
  • Long H; Center for Functional Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Yao J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. MD Anderson Cancer Center, Houston, Texas.
  • Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Center for Functional Epigenetics, Dana-Farber Cancer Institute, Bo
Cancer Res ; 75(7): 1516-26, 2015 Apr 01.
Article en En | MEDLINE | ID: mdl-25670169
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Tirosina Quinasas / Neoplasias de la Mama / Proteínas Serina-Treonina Quinasas / Empalme Alternativo Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Tirosina Quinasas / Neoplasias de la Mama / Proteínas Serina-Treonina Quinasas / Empalme Alternativo Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2015 Tipo del documento: Article